A Case Study on the "Sinicization" of Business Development of Medical Enterprises – Medtronic
DOI:
https://doi.org/10.54691/bcpbm.v34i.3014Keywords:
Medtronic Corporation; Medical company; Medical economic benefits.Abstract
Although in recent years, people think that the health care industry development has a great prospect, but with the development of the outbreak, and more and more enterprises start to the discovery of this huge medical demand in China, the Chinese medical market has great just need not be met, the Chinese medical market will be in the future will not only become the world's largest medical device market, and it will certainly become one of the most important sources of innovation for medical devices worldwide. More and more foreign medical companies want to enter the Chinese market. However, there are many obstacles in the process of realizing localization, and the transformation of many companies has not achieved significant effects, and the performance of the Chinese market has declined rather than increased. This article will be the world medical industry giant - Medtronic medical company as a case study, analysis of the current situation, put forward some suitable for China's national conditions of the medical development road, in order to seize more market share, to achieve economic value increase.
Downloads
References
George B, Kindred N. Omar Ishrak, Building Medtronic Globally. Harvard Business School Case Study, 2013: 9-413.
Nielsen C. Valuation of the company Medtronic. 2019: 1-78.
Lee D H, Yoon S N. Application of artificial intelligence-based technologies in the healthcare industry: Opportunities and challenges. International Journal of Environmental Research and Public Health, 2021, 18(1): 271.
Zheng X, Rodríguez-Monroy C. The development of intelligent healthcare in China. Telemedicine and e-Health, 2015, 21(5): 443-448.
George W W. Medtronic's chairman William George on how mission-driven companies create long-term shareholder value. Academy of Management Perspectives, 2001, 15(4): 39-47.
Chaudhuri A. Supply chain innovations in healthcare. Innovations in healthcare management: Cost-effective and sustainable solutions, 2015: 261-272.
Khan S, Haleem A, Deshmukh S G, et al. Exploring the impact of COVID-19 pandemic on medical supply chain disruption. Journal of Industrial Integration and Management, 2021, 6(02): 235-255.
Goodarzian F, Taleizadeh A A, Ghasemi P, et al. An integrated sustainable medical supply chain network during COVID-19. Engineering Applications of Artificial Intelligence, 2021, 100: 104188.
Rose-Ackerman S, Yan Y. Corruption in the Procurement of Pharmaceuticals and Medical Equipment in China. UCLA Pac. Basin LJ, 2014, 32.
Van Tonder E. Trust and commitment as mediators of the relationship between quality advice and customer loyalty. 2016.
TURNER, Leigh. “Medical tourism” and the global marketplace in health services: US patients, international hospitals, and the search for affordable health care. International Journal of Health Services, 2010, 40.3: 443-467.
LIEB, Klaus; KOCH, Cora. Medical students’ attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals. Deutsches Ärzteblatt International, 2013, 110.35-36: 584.
Chang Y Y, Hodgkinson I, Hughes P, et al. The mediation between participative leadership and employee exploratory innovation: Examining intermediate knowledge mechanisms. Leadership & Organization Development Journal, 2019.
Chen W W, Gao R L, Liu L S, et al. China cardiovascular diseases report 2015: a summary. Journal of geriatric cardiology: JGC, 2017, 14(1): 1-10.
Sorenson C, Drummond M, Khan B B. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clinic Economics and outcomes research: CEOR, 2013, 5: 223.
Downloads
Published
Issue
Section
How to Cite
